title: Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004.
abstract: Pneumococci (n = 1033) isolated in the major paediatric hospitals of Athens during 2001-2004 from children with invasive infections (n = 186), non-invasive infections (n = 641) and healthy carriers (n = 206) were studied. The most prevalent serotypes were serotypes 14 (44.6%), 19F (43.5%) and 6B (22.8%) in invasive, non-invasive and carriage isolates, respectively. Among invasive isolates, the potential coverage by the seven-valent conjugate vaccine was 75.3%. Resistance rates to penicillin, amoxycillin, cefotaxime, erythromycin, co-trimoxazole, clindamycin, tetracycline and chloramphenicol were 44.6%, 2.7%, 1.2%, 43.6%, 43.5%, 12.4%, 34.7% and 5.9%, respectively. The M-phenotype accounted for 68.0% of the erythromycin-resistant isolates. All isolates were susceptible to ofloxacin.
authors.affiliation: Clinical Microbiology Department of P. & A. Kyriakou (Annexe), Medical School, University of Athens, Aristofanous 56-58, Athens 152 32, Greece. ireparaskakis@yahoo.gr
authors.forename: I
authors.initials: I
authors.lastname: Paraskakis
authors.forename: D A
authors.initials: DA
authors.lastname: Kafetzis
authors.forename: A
authors.initials: A
authors.lastname: Chrisakis
authors.forename: H
authors.initials: H
authors.lastname: Papavasilliou
authors.forename: H
authors.initials: H
authors.lastname: Kirikou
authors.forename: A
authors.initials: A
authors.lastname: Pangalis
authors.forename: L S
authors.initials: LS
authors.lastname: Tzouvelekis
authors.forename: T
authors.initials: T
authors.lastname: Athanasiou
authors.forename: N J
authors.initials: NJ
authors.lastname: Legakis
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002648:Child; D002675:Child, Preschool; D024881:Drug Resistance, Bacterial; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006115:Greece / Q000453:epidemiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008826:Microbial Sensitivity Tests; D011008:Pneumococcal Infections / Q000453:epidemiology / Q000382:microbiology*; D022242:Pneumococcal Vaccines / Q000276:immunology; D012703:Serotyping; D013296:Streptococcus pneumoniae / Q000145:classification* / Q000187:drug effects* / Q000276:immunology / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D022242:Pneumococcal Vaccines